BRAF inhibitors are drugs designed to specifically target and inhibit the activity of the mutated B-Raf protein. By blocking this protein, these inhibitors can reduce the proliferation of cancer cells. They are particularly effective in treating cancers with the BRAF V600E mutation. However, resistance to BRAF inhibitors can develop, necessitating combination therapies or alternative treatment strategies.
